Jesper Söderqvist, Ph.D
Board Member & Chairman Audit Committee
Jesper Söderqvist, PhD (born 1966), Board Member since 2013.
Nationality: Swedish.
Education/Background: Master of Science in Engineering from KTH Royal Institute of Technology and PhD in Physics from KTH/CERN. Former CEO of Arcoma, Vice President of Elekta AB’s neuroscience division, General Manager of mammography at Philips Healthcare, and CEO of Sectra Mamea.
Current positions: CEO of Boule Diagnostics AB, Board Member of Arcoma AB, and Board Member & CEO of Dekatria AB.
Holdings directly and indirectly: 94 489 A-Shares, 365 029 B-Shares, 105 000 LTIP instruments.
Independent of the company, its management, and major shareholders.
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects